129 related articles for article (PubMed ID: 18831925)
1. Quantification of sirolimus and everolimus by immunoassay techniques: test specificity and cross-reactivity evaluation.
Pieri M; Miraglia N; Gentile A; Polichetti G; Castiglia L; Federico S; Sabbatini M; Basile V; Tarantino G; Acampora A; Capone D
Int J Immunopathol Pharmacol; 2008; 21(3):585-94. PubMed ID: 18831925
[TBL] [Abstract][Full Text] [Related]
2. Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay.
Bouzas L; Tutor JC
Clin Biochem; 2007 Jan; 40(1-2):132-6. PubMed ID: 17011541
[TBL] [Abstract][Full Text] [Related]
3. Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method.
Bouzas L; Hermida J; Tutor JC
Ups J Med Sci; 2009; 114(1):55-61. PubMed ID: 19242874
[TBL] [Abstract][Full Text] [Related]
4. Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.
Coentrão L; Carvalho C; Sampaio S; Oliveira JG; Pestana MI
Transplant Proc; 2010 Jun; 42(5):1867-9. PubMed ID: 20620539
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation.
Baldelli S; Crippa A; Gabrieli R; Fiocchi R; Perico N; Merlini S; Ottomano C; Cattaneo D
Clin Biochem; 2006 Dec; 39(12):1152-9. PubMed ID: 17054930
[TBL] [Abstract][Full Text] [Related]
6. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
Khoschsorur G; Fruehwirth F; Zelzer S; Stettin M; Halwachs-Baumann G
Clin Chim Acta; 2007 May; 380(1-2):217-21. PubMed ID: 17320846
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients.
Salm P; Warnholtz C; Boyd J; Arabshahi L; Marbach P; Taylor PJ
Clin Biochem; 2006 Jul; 39(7):732-8. PubMed ID: 16725133
[TBL] [Abstract][Full Text] [Related]
8. Stability of sirolimus and everolimus measured by immunoassay techniques in whole blood samples from kidney transplant patients.
Capone D; Gentile A; Polichetti G; Federico S; Sabbatini M; Acampora A; Basile V; Pieri M; Tarantino G
Int J Immunopathol Pharmacol; 2008; 21(2):297-307. PubMed ID: 18547473
[TBL] [Abstract][Full Text] [Related]
9. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
[TBL] [Abstract][Full Text] [Related]
10. Crossreactivity of isolated everolimus metabolites with the Innofluor Certican immunoassay for therapeutic drug monitoring of everolimus.
Strom T; Haschke M; Boyd J; Roberts M; Arabshahi L; Marbach P; Christians U
Ther Drug Monit; 2007 Dec; 29(6):743-9. PubMed ID: 18043471
[TBL] [Abstract][Full Text] [Related]
11. Comparison between a liquid chromatography-tandem mass spectrometry assay and a fluorescent polarization immunoassay to measure whole blood everolimus concentration in heart and renal transplantations.
Dailly E; Deslandes G; Hourmant M; Petit T; Renaud C; Treilhaud M; Jolliet P
J Clin Lab Anal; 2008; 22(4):282-5. PubMed ID: 18623123
[TBL] [Abstract][Full Text] [Related]
12. Determination of everolimus in blood samples from kidney and liver transplant recipients using the sirolimus chemiluminescence magnetic microparticle immunoassay (CMIA) on the Architect-i1000® system.
Hermida-Cadahia EF; Tutor JC
Scand J Clin Lab Invest; 2012 Apr; 72(2):180-3. PubMed ID: 22248047
[TBL] [Abstract][Full Text] [Related]
13. Larger dosage required for everolimus than sirolimus to maintain same blood concentration in two pancreatic islet transplant patients with tacrolimus.
Sato E; Yano I; Shimomura M; Masuda S; Katsura T; Matsumoto S; Okitsu T; Iwanaga Y; Uemoto S; Inui K
Drug Metab Pharmacokinet; 2009; 24(2):175-9. PubMed ID: 19430174
[TBL] [Abstract][Full Text] [Related]
14. Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus.
Wilson D; Johnston F; Holt D; Moreton M; Engelmayer J; Gaulier JM; Luthe H; Marquet P; Moscato D; Oellerich M; Mosso R; Streit F; Brunet M; Fillee C; Schmid R; Wallemacq P; Barnes G
Clin Biochem; 2006 Apr; 39(4):378-86. PubMed ID: 16545357
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients.
Morris RG; Salm P; Taylor PJ; Wicks FA; Theodossi A
Ther Drug Monit; 2006 Apr; 28(2):164-8. PubMed ID: 16628125
[TBL] [Abstract][Full Text] [Related]
17. Immunoassay determination of rapamycin: reliability of the method with respect to liquid chromatography mass spectrometric quantification.
Pieri M; Capone D; Gentile A; Miraglia N; Leo E; Federico S; Basile V; Acampora A
Clin Transplant; 2007; 21(5):633-7. PubMed ID: 17845638
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the CEDIA and MEIA assays for the measurement of sirolimus in organ transplant recipients.
Colantonio DA; Borden KK; Clarke W
Clin Biochem; 2007 Jun; 40(9-10):680-7. PubMed ID: 17428457
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new immunoassay to measure sirolimus blood concentrations compared to a tandem mass-spectrometric chromatographic analysis.
Fillée C; Mourad M; Squifflet JP; Malaise J; Lerut J; Reding R; Borghgraef P; Vanbinst R; Wallemacq PE
Transplant Proc; 2005; 37(6):2890-1. PubMed ID: 16182845
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of QMS everolimus assay using Hitachi 917 Analyzer: comparison with liquid chromatography/mass spectrometry.
Dasgupta A; Davis B; Chow L
Ther Drug Monit; 2011 Apr; 33(2):149-54. PubMed ID: 21266941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
